E. Garattini, M. Giannı́, M. Terao
Apr 1, 2002
Citations
0
Influential Citations
1
Citations
Journal
Cancer research
Abstract
The retinoid 6-[-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437) is the prototype of a new class of promising anticancer agents endowed with strong and selective apoptogenic properties against different types of neoplastic cells [(1][1], [2][2], [3)][3] . The compound is active